Updated
Contineum TherapeuticsCTNM · Healthcare
$9.52+8.06%
Market cap$374M
IndustryBiotechnology

Contineum Therapeutics (CTNM) Superinvestor holders

5 of the superinvestors we track hold Contineum Therapeutics (CTNM) in their latest 13F filings, $15M in total.

Summary

The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $11M, 1.3% of the portfolio.

In their latest quarter: 4 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Zhang Lei
Hillhouse (HHLR Advisors)
Held 669,337$11M 1.3%Q2 2026
Paul Marshall
Marshall Wace
Trimmed 118,058$2M 0.0%Q2 2026
Jim Simons
Renaissance Technologies
Trimmed 67,300$1M 0.0%Q2 2026
Two Sigma
Two Sigma Investments
Trimmed 30,347$497,387 0.0%Q2 2026
Steve Cohen
Point72 Asset Management
Trimmed 25,779$422,518 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 20265
Q1 20267
Q4 20258
Q3 20256
Q2 20257
Q1 20252
Q4 20242
Q3 20241

Questions about Contineum Therapeutics

Which superinvestors own Contineum Therapeutics?

5 of the superinvestors we track hold Contineum Therapeutics (CTNM) in their latest 13F filings, $15M in total. Zhang Lei, Paul Marshall, Jim Simons, Two Sigma, Steve Cohen.

Who is the largest superinvestor holder of CTNM?

The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $11M, 1.3% of the portfolio.

From Contineum Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Contineum Therapeutics and thousands of other companies, in one place. Free to start.